Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/f2/5e/1b/f25e1b4b-1867-3e6b-a958-3f370141e49b/mza_6796281444641925643.jpg/600x600bb.jpg
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
American Geriatrics Society
7 episodes
1 week ago
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
Show more...
Medicine
Health & Fitness
RSS
All content for AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast is the property of American Geriatrics Society and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
Show more...
Medicine
Health & Fitness
Episodes (7/7)
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
Show more...
3 weeks ago
26 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheim...
Show more...
3 weeks ago
16 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What ...
Show more...
4 weeks ago
32 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of...
Show more...
4 weeks ago
23 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Disease (CEAD), Director of University Geriatricians, and Chair of the Department of Geriatrics at SUNY Upstate University Hospital; and Dr. Alejandra Sanchez Lopez, Assistant Clinical Professor of Neurology and Geriatric Medicine at UCLA, as they discuss ...
Show more...
4 weeks ago
20 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Evaluation of Cognition and Cognitive Disorder
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Director, Johns Hopkins Memory and Alzheimer's Treatment Center and; Dr. Mfon E. Umoh, Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, as they discuss Evaluation of Cognition and ...
Show more...
4 weeks ago
28 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Pathology and Diagnostic Frameworks for Alzheimer Disease
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-director of the Duke/UNC Alzheimer’s Disease Research Center, as they discuss Pathology and Diagnostic Frameworks for Alzheimer Disease. To view a transcript click here then select the transcript tab.
Show more...
4 weeks ago
24 minutes

AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.